Largest Greek (ASE) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Dec 23, 2025

Discover large cap Greek Pharmaceuticals & Biotech companies that are on the ASE. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	LAVI Lavipharm	€0.96	5.5%	26.1%	€161.6m	n/a	PE78.2x	n/a	2.1%